SABBY Management, LLC, 10% Owner at Celsus Therapeutics Plc. (CLTX), bought 16,203 shares at $6.86 ($108K) on 2014-03-26, disclosed to the SEC on 2014-03-27.
Open-market purchase of $108k CLTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.90 | 303 | $2K | 1.9% |
| 2 | $6.65 | 13,300 | $88K | 81.9% |
| 3 | $6.86 | 900 | $6K | 5.7% |
| 4 | $6.61 | 1,700 | $11K | 10.4% |
| Total | $6.66 avg | 16,203 | $108K | 100% |
| Filing → |
| VLCN | BUY | 2024-08-28 | $5K | — | Filing → |
| VLCN | BUY | 2024-08-26 | $11K | — | Filing → |
| VLCN | SELL | 2024-08-26 | $134K | — | Filing → |